<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clustering of classical <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> is insufficient to account for the excess <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> (CAD) of patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (IR) are obvious culprits </plain></SENT>
<SENT sid="1" pm="."><plain>Whole-body and skeletal muscle IR is characteristic of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but whether it extends to the normally contracting cardiac muscle is controversial </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated whether type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with myocardial IR independent of CAD in a case-control series (n = 55) of male nondiabetic and diabetic (type 2 and type 1) patients with or without angiographically documented CAD </plain></SENT>
<SENT sid="3" pm="."><plain>Baseline blood flow ((15)O-water) and insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake ((18)F-fluoro-<z:chebi fb="0" ids="15866">deoxyglucose</z:chebi>) during euglycemic (5.6 mmol/l), physiological <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> (40 mU x min(-1) x m(-2) insulin clamp) were measured by <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography in skeletal muscle and normally contracting myocardium </plain></SENT>
<SENT sid="4" pm="."><plain>Skeletal muscle <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake was reduced in association with both CAD and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In regions with <z:mpath ids='MPATH_458'>normal</z:mpath> baseline perfusion, insulin-mediated myocardial <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake was reduced in non-CAD type 2 diabetic (0.36 +/- 0.14 micro mol x min(-1) </plain></SENT>
<SENT sid="6" pm="."><plain>g(-1)) and nondiabetic CAD patients (0.44 +/- 0.15 micro mol x min(- 1) x g(-1)) in comparison with healthy control subjects (0.61 +/- 0.08) or with non-CAD type 1 diabetic patients (0.80 +/- 0.13; P &lt; 0.001 for both CAD and <z:mp ids='MP_0002055'>diabetes</z:mp>) </plain></SENT>
<SENT sid="7" pm="."><plain>Neither basal skeletal muscle nor basal myocardial blood flow differed across groups; both skeletal muscle and myocardial IR were directly related to whole-body IR </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is specifically associated with myocardial IR that is independent of and nonadditive with angiographic CAD and proportional to skeletal muscle and whole-body IR </plain></SENT>
</text></document>